Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 4:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 4
1 (33.3%)Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- Device: Use of ologen Collagen Matrix in trabeculectomy (ologen)Drug: Use of Mitomycin-C (MMC) in trabeculectomy
- First Posted Date
- 2011-09-27
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- Aeon Astron Europe B.V.
- Target Recruit Count
- 99
- Registration Number
- NCT01440751
- Locations
- πΊπΈ
VoldVision-Holf Eye Clinic, Rogers, Arkansas, United States
πΊπΈNorthwestern Memorial Hospital, Chicago, Illinois, United States
πΊπΈInstitue of Ophthalmology and Visual Science, Newark, New Jersey, United States
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany
Not Applicable
- Conditions
- Open-angle Glaucoma
- Interventions
- Device: Use of ologen Collagen Matrix in trabeculectomyDrug: Use of Mitomycin-C in trabeculectomy
- First Posted Date
- 2010-08-03
- Last Posted Date
- 2011-05-09
- Lead Sponsor
- Aeon Astron Europe B.V.
- Target Recruit Count
- 40
- Registration Number
- NCT01174420
- Locations
- π©πͺ
The University Hospital of Cologne, Cologne, Germany
News
No news found